IESE opens a new call for Proposals for the Barcelona Technology Transfer Group Blog Post

IESE Business School opens their 7th Edition of the program of the Barcelona Technology Transfer Group (BTTG), a collaboration program between MBA students and successful mentors with scientists, technologist and entrepreneurs of public and private centres, with the intention of helping create a company or boost their first stages of development. Barcelona Science Park collaborates in this initiative within the strategic agreement set on last January with IESE to promote and support the growth of business initiatives of life sciences.

Researchers identify a molecular auto-control system to avoid an excessive brown adipose tissue activity Blog Post

A scientific team found, lead by Professor Francesc Villarroya, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB) present in PCB, found a new molecular auto-control system of lipidic metabolism, so far unknown, could help prevent the damaging effects derived from an excessive activation of the brown adipose tissue. The study is published in the journal Nature Communications.

 

The FDA licenses Chemotargets CLARITY platform Blog Post

Chemotargets –a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park– has signed a license agreement for its CLARITY® platform with the Food and Drug Administration (FDA) to provide adverse event predictions and mechanistic investigation in public health risk assessments of new drug applications and existing marketed products.

 

Barcelona Science Park announces a new artistic intervention contest to decorate an outdoor space Blog Post

Barcelona Science Park (PCB) announces a new artistic intervention contest to promote the interaction between art and science. The public and anonymous event offers the opportunity to create, with total thematic freedom, a mural in an outdoor space of 4.5 metres of height per 6.5 metres of width in the Clúster II building, in a junction of various areas of the park at different levels.

 

Avinent collaborates with Althaia and other institutions to produce PPE with 3D printing technology Blog Post

The company Avinent, present in the Barcelona Science Park, is doing a collaborative project with Althaia Foundation, Bages University Foundation (FUB-UManresa), Eurecat, the Universitat Politécnica de Cataluña (UPC) and Manresa City Council to produce Personal Protective Equipment (PPE) with 3D printing technology. This alliance is concreted with the fabrication of face protection screens and door handles to open with the forearm.

 

Chemotargets opens an investment round to enter a new phase of growth Blog Post

Chemotargets, a global leader in predictive analytics solutions for the pharma and biotech sector, begins a phase of transformation to expand its activity in the drug discovery sector as a biotechnology company. The company, based in the Barcelona Science Park, is opening an investment round to undertake the transformation of its business model, with tadvice and support of GENESIS Biomed, also located in the Park, and CREA Inversión. 

 

Dreamers Startup Ventures signs an agreement to invest up to $1.1M in Oncoheroes Biosciences Blog Post

Dreamers Startup Ventures has committed to invest up to $1.1M in Oncoheroes Biosciences, a biotech company exclusively focused on the development of innovative medicines to treat cancer in children and adolescents. Oncoheroes was co-founded by Ricardo Garcia and Cesare Spadoni, two parents touched by childhood cancer and determined to change the outlook for these young patients. Founded at Boston, the company has the European headquarters at the Barcelona Scientific Park where its discovery lab looks for novel targets and molecules.